ACR Convergence

Advances in Giant Cell Arteritis

Philip Seo, MD, MHS | November 14, 2025

Dr. Philip Seo highlights the latest research into the assessment and treatment of giant cell arteritis presented during ACR Convergence 2025.

ACR Releases New Guideline for Management of SLE at ACR 2025

Mithu Maheswaranathan, MD | November 14, 2025

Updating the last iteration in 1999, the new ACR Guideline for Management of SLE was unveiled at ACR Convergence 2025, providing rheumatologists an organ-based approach for therapeutic options for specific lupus manifestations.

Complementary Medicine Meets Rheumatology: New Ways to Reduce Inflammation

Ruth Jessen Hickman, MD | November 14, 2025

At this ACR Convergence 2025 session, the speaker highlighted ways complementary and alternative medicine can be used alongside traditional medical treatments.

ARP Year in Review: Updates in Advanced Practice, Epidemiology & Rehabilitation

Catherine Kolonko | November 12, 2025

Three experts discussed recent notable research of interest to rheumatology professionals across a range of topics.

Secrets & Pearls of Rheumatology at ACR Convergence 2025

Mithu Maheswaranathan, MD | November 12, 2025

Two clinical diagnosticians presented their pearls of wisdom for clinical rheumatologists to take forward when managing patients from the clinics to the hospital wards.

The ACR Revamps RISE Registry into a Productivity & Learning Tool

Mary Beth Nierengarten | November 10, 2025

The ACR’s new RISE Registry, set for 2026, will be a modern productivity tool with new analytics, easy EHR connection & robust research data.

ACR Advocacy Update 2025, Federal & State

Mary Beth Nierengarten | November 9, 2025

ACR representatives outlined its 2025 legislative priorities, including fixing the MPFS, reforming prior authorization & protecting telehealth reimbursement.

As Understanding of Long COVID Deepens, the Search for Therapies Continues

Thomas R. Collins | November 7, 2025

Experts discussed causes of long COVID & potential therapies at this ACR Convergence 2025 session.

No Longer as Vexing: The Role of Somatic Mutations in Rheumatic Diseases

Jason Liebowitz, MD, FACR | November 7, 2025

At this ACR Convergence 2025 session, two experts discussed VEXAS & the role that genetic sequencing should play in the practice of a rheumatologist.

Collaboration Is Key to Oral Health in Scleroderma & Sjögren’s Disease

Catherine Kolonko | November 7, 2025

At this ACR Convergence 2025 session, experts discussed the oral manifestations of scleroderma & Sjögren’s disease & the importance of dentists & rheumatologists working together.